- Home
- MDGL vs ELP Comparison
MDGL vs ELP Comparison
Compare MDGL & ELP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- ELP
- Stock Information
- Founded
- MDGL 2011
- ELP 1954
- Country
- MDGL United States
- ELP Brazil
- Employees
- MDGL N/A
- ELP N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- ELP Electric Utilities: Central
- Sector
- MDGL Health Care
- ELP Utilities
- Exchange
- MDGL Nasdaq
- ELP Nasdaq
- Market Cap
- MDGL 6.1B
- ELP 6.2B
- IPO Year
- MDGL N/A
- ELP 1997
- Fundamental
- Price
- MDGL $302.17
- ELP $8.68
- Analyst Decision
- MDGL Strong Buy
- ELP
- Analyst Count
- MDGL 9
- ELP 0
- Target Price
- MDGL $420.63
- ELP N/A
- AVG Volume (30 Days)
- MDGL 371.3K
- ELP 317.8K
- Earning Date
- MDGL 08-05-2025
- ELP 08-15-2025
- Dividend Yield
- MDGL N/A
- ELP 5.08%
- EPS Growth
- MDGL N/A
- ELP 31.95
- EPS
- MDGL N/A
- ELP 0.17
- Revenue
- MDGL $317,383,000.00
- ELP $4,033,509,015.00
- Revenue This Year
- MDGL $286.67
- ELP N/A
- Revenue Next Year
- MDGL $67.98
- ELP $6.56
- P/E Ratio
- MDGL N/A
- ELP $12.12
- Revenue Growth
- MDGL N/A
- ELP 6.92
- 52 Week Low
- MDGL $200.63
- ELP $5.72
- 52 Week High
- MDGL $377.46
- ELP $9.28
- Technical
- Relative Strength Index (RSI)
- MDGL 48.85
- ELP 51.61
- Support Level
- MDGL $286.44
- ELP $8.40
- Resistance Level
- MDGL $312.05
- ELP $8.71
- Average True Range (ATR)
- MDGL 14.84
- ELP 0.18
- MACD
- MDGL -3.14
- ELP 0.02
- Stochastic Oscillator
- MDGL 22.01
- ELP 86.35
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About ELP Companhia Paranaense de Energia (COPEL) (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)
Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.